Examining the Immune Response in Patients With Gaucher Disease and Hepatitis C
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01274208|
Recruitment Status : Unknown
Verified November 2014 by Ari Zimran, Shaare Zedek Medical Center.
Recruitment status was: Recruiting
First Posted : January 11, 2011
Last Update Posted : November 19, 2014
Shaare Zedek Medical Center
Information provided by (Responsible Party):
Ari Zimran, Shaare Zedek Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||March 2016|
|Estimated Study Completion Date :||April 2016|
Publications of Results:
Zigmond E LG, Pappo O, Zangen S, Levy Sklair M, Hemed N, Rabbani E, Itamar R, Ilan Y, Margalit M. Treatment of non-alcoholic steatohepatitis by B-glucosylceramide: A phase I/II clinical study. Hepatology 2006;44 .180A, .
Elstein D, Abrahamov A, Hadas-Halpern I, Zimran A. Gaucher's disease. Lancet. 2001 Jul 28;358(9278):324-7.
Beutler E. Gaucher disease: multiple lessons from a single gene disorder. Acta Paediatr Suppl. 2006 Apr;95(451):103-9. Review.
Slatkin M. A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases. Am J Hum Genet. 2004 Aug;75(2):282-93. Epub 2004 Jun 18.